https://investorsmedia.mesoblast.com/static-files/e14d0449-ba07-4755-815d-99adf40ddc17
There have been a number of scenarios of Real World Evidence (RWE) that IMO support Mesoblast's decision to plan to run and additional COVID-19 ARDS Phase 3 trial using Remestemcel-L ... I thought we could use this thread to post them as we come across them ? Use the thread or don't use it; entirely up to you
An exponential increase in case numbers like this - 1,044,970 new cases in one day and USA hospitalisations up by 41% in two weeks would IMO support SI's reasons for undertaking an additional COVID-19 ARDS Phase 3 trial in the USA using our Remestemcel-L treatment.
https://www.nbcnews.com/news/us-new...-covid-cases-spread-omicron-variant-rcna10866
U.S. reaches 1 million daily Covid cases in spread of omicron variant
RWE for 2nd MSB COVID-19 ARDS P3 Trial
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.120(9.76%) |
Mkt cap ! $1.267B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.11 | $14.06M | 12.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 168043 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 27647 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.12 |
Change
-0.120 ( 9.28 %) |
||||
| Open | High | Low | Volume | ||
| $1.20 | $1.20 | $1.12 | 1823761 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| MSB (ASX) Chart |